Apoptosis and Metabolic Reprogramming by RHART in Hepatocellular Carcinoma Through the CPSF6 / MCT4 /c‐Myc Signaling In Vitro and In Vivo
Phytotherapy Research · 2026-05 · 40 (5) · 2556-2568
DOI: 10.1002/ptr.70284 ↗At a glance
Journal article in Phytotherapy Research, published online on 2026-02-18. Written by Youngsang Park and 6 co-authors. Institution: College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea. Major MEDLINE topics: Apoptosis, Carcinoma, Hepatocellular, Liver Neoplasms, Plant Extracts. Cited 1 times so far (Crossref); 38 references. Funded by: National Research Foundation of Korea.
Abstract (original language)
Though Rhus verniciflua and Artemisia capillaris have been traditionally prescribed for liver ailments, the molecular antitumor mechanism of their ethanol extract (RHART) remains undefined in hepatocellular carcinoma (HCC). Thus, this study aimed to elucidate the apoptotic mechanisms of RHART, focusing on its regulation of oncogenic drivers—cleavage and polyadenylation specificity factor 6 (CPSF6), monocarboxylate transporter 4 (MCT4), and c‐Myc—and glycolysis‐related pathways. RHART quality was standardized by HPLC fingerprinting. Cytotoxicity, apoptosis, and protein expression were analyzed using MTT, cell cycle, and Western blot assays in RHART‐treated Hep3B and Huh7 cells. Functional rescue assays were conducted by overexpressing CPSF6 or c‐Myc, while CPSF6–MCT4 interaction was confirmed by immunoprecipitation. The in vivo efficacy of RHART was validated using Hep3B xenografts in BALB/c nude mice followed by immunohistochemistry. RHART treatment induced pronounced cytotoxicity and apoptosis, as indicated by an elevated sub‐G1 population and cleavage of PARP and caspase‐3. RHART markedly downregulated CPSF6, MCT4, c‐Myc, and glycolytic enzymes (HK2, PKM2, LDHA), thereby reducing glucose utilization and lactate output. CPSF6 directly interacted with MCT4, and overexpression of CPSF6 or c‐Myc counteracted the capacity of RHART to induce apoptosis and metabolic reprogramming. In vivo, RHART significantly suppressed tumor growth and expression of CPSF6, MCT4, PCNA, and PKM2, while enhancing cleaved caspase‐3. These findings provide scientific evidence that RHART induces apoptotic and metabolic reprogramming effects in hepatocellular carcinoma by targeting the CPSF6/MCT4/c‐Myc signaling axis, underscoring its potential as a novel natural therapeutic candidate for liver cancer.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
- School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
ORCID profiles: Bonglee Kim, Ki Hyun Kim
Funding
- National Research Foundation of Korea
Cite
APA
Park, Y., Park, S. Y., Kim, B., Shim, B. S., Joh, Y. S., Kim, K. H., & Kim, S. H. (2026). Apoptosis and Metabolic Reprogramming by RHART in Hepatocellular Carcinoma Through the CPSF6 / MCT4 /c‐Myc Signaling In Vitro and In Vivo. Phytotherapy Research, 40(5), 2556-2568. https://doi.org/10.1002/ptr.70284
Vancouver
Park Y, Park SY, Kim B, Shim BS, Joh YS, Kim KH, et al. Apoptosis and Metabolic Reprogramming by RHART in Hepatocellular Carcinoma Through the CPSF6 / MCT4 /c‐Myc Signaling In Vitro and In Vivo. Phytotherapy Research. 2026;40(5):2556-2568. doi:10.1002/ptr.70284
BibTeX
@article{Park2026,
author = {Park, Youngsang and Park, Su-Yeon and Kim, Bonglee and Shim, Bum-Sang and Joh, Yun Seok and Kim, Ki Hyun and Kim, Sung-Hoon},
title = {Apoptosis and Metabolic Reprogramming by RHART in Hepatocellular Carcinoma Through the CPSF6 / MCT4 /c‐Myc Signaling In Vitro and In Vivo},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {5},
pages = {2556--2568},
doi = {10.1002/ptr.70284}
}
EUVIMED